Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study of Weekly Oral GS-1720 and GS-4182 for Untreated HIV-1 Patients
GermanyStudy on the Safety and Effectiveness of Saroglitazar Magnesium for Patients with Primary Biliary Cholangitis
IcelandStudy of Deucrictibant Extended-Release Tablets for Prevention of Hereditary Angioedema Attacks in Adults and Adolescents
BulgariaStudy on Masitinib for Treating Primary or Secondary Progressive Multiple Sclerosis in Patients Without Relapse
FranceStudy Comparing CT-P55 and Secukinumab for Moderate to Severe Plaque Psoriasis Patients
PolandStudy on the Effectiveness and Safety of Benralizumab with Budesonide and Formoterol in Patients with Eosinophilic Asthma Uncontrolled by Standard Treatment
BulgariaStudy on the Safety and Effects of DNTH103 for Adults with Multifocal Motor Neuropathy
DenmarkStudy of Long-Acting Cabotegravir and Rilpivirine for People Aged 60 and Over Living with HIV-1
SpainStudy on Long-Term Safety of Tegoprubart and Tacrolimus for Preventing Kidney Transplant Rejection in Patients
FranceStudy on the Long-Term Safety of Obeticholic Acid and Bezafibrate for Patients with Primary Biliary Cholangitis
BelgiumStudy on the Safety and Effectiveness of Adalimumab as Initial Treatment for Newly Diagnosed Crohn's Disease Patients
The NetherlandsStudy on HIV Treatment Interruption in Children with Perinatal HIV Using Lamivudine and Drug Combination
ItalyThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
